Ionis Pharmaceuticals, Inc. (IONS)
83.15
0.00 (0.00%)
USD |
NASDAQ |
Feb 20, 16:00
84.01
+0.86
(+1.03%)
After-Hours: 20:00
Ionis Pharmaceuticals Shareholders Equity (Quarterly) : 617.97M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Biogen, Inc. | 18.26B |
| Alnylam Pharmaceuticals, Inc. | 789.18M |
| Twist Bioscience Corp. | 456.10M |
| Catalyst Pharmaceuticals, Inc. | 920.24M |
| Cytokinetics, Inc. | -521.12M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 3.033B |
| Total Liabilities (Quarterly) | 2.415B |
| Debt to Equity Ratio | 3.315 |
| Current Ratio | 2.788 |
| Net Debt Paydown Yield | -0.14% |